Board changes at Benitec, Ventracor, BioDiem
Thursday, 17 February, 2005
The management changes at RNAi player Benitec (ASX:BLT) continued yesterday, with the announcement that company secretary Gary Taylor had resigned as a director of the company. Taylor will remain company secretary.
Ventracor (ASX:VCR) has appointed medical devices executive Peter Crosby as chief operating officer. Crosby -- an Australian who has served as CEO of four international medical device companies -- will take on the marketing, sales and distribution of Ventracor's VentAssist device.
BioDiem (ASX:BDM) has appointed former Deutsche Bank executive Andrew O'Brien to its board as a non-executive director. O'Brien headed the Australian healthcare corporate finance at Deutsche Bank, and currently works for consulting firm BioIncyte.
Novel antibiotic activates 'suicide' mechanism in superbug
Researchers have discovered a new class of antibiotic that selectively targets Neisseria...
Modifications in the placenta linked to psychiatric disorders
Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...
ADHD may be linked with an increased risk of dementia
An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...
